Related references
Note: Only part of the references are listed.Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier
Patrick D. McGillivray et al.
EUROPEAN UROLOGY (2021)
Searching for prognostic biomarkers for small renal masses in the urinary proteome
Ashley Di Meo et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Association of elevated C-reactive protein with oncologic outcomes in renal CELL carcinoma: A multicenter analysis.
Sunil Hemant Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David J. Clark et al.
CELL (2019)
Kidney Cancer, Version 2.2020 Featured Updates to the NCCN Guidelines
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Use of delayed intervention for small renal masses initially managed with active surveillance
Mohit Gupta et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management
Andrew W. Silagy et al.
EUROPEAN UROLOGY FOCUS (2019)
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States
Hiten D. Patel et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide
Scott P. Campbell et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes
Andrew G. McIntosh et al.
EUROPEAN UROLOGY (2018)
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
Bimal Bhindi et al.
EUROPEAN UROLOGY (2018)
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
Sumanta K. Pal et al.
EUROPEAN UROLOGY (2017)
Use of liquid biopsy for detection of renal cell carcinoma.
Dean Laganosky et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Renal Mass and Localized Renal Cancer: AUA Guideline
Steven Campbell et al.
JOURNAL OF UROLOGY (2017)
Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma
Oluyemi S. Falegan et al.
METABOLITES (2017)
Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma
Martin H. Voss et al.
BRITISH JOURNAL OF CANCER (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study
Mark W. Ball et al.
CLINICAL GENITOURINARY CANCER (2016)
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
Lorenzo Marconi et al.
EUROPEAN UROLOGY (2016)
Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature
Hiten D. Patel et al.
JOURNAL OF UROLOGY (2016)
A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses
Hiten D. Patel et al.
UROLOGY (2016)
Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps
Hong Zheng et al.
ONCOTARGET (2016)
Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma
Parth K. Modi et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Prognostic Value of Plasma and Urine glycosaminoglycan scores in clear cell renal cell carcinoma
Francesco Gatto et al.
FRONTIERS IN ONCOLOGY (2016)
Urine Aquaporin 1 and Perilipin 2 Differentiate Renal Carcinomas From Other Imaged Renal Masses and Bladder and Prostate Cancer
Jeremiah J. Morrissey et al.
MAYO CLINIC PROCEEDINGS (2015)
The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis
Qingfeng Hu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
The metabolic basis of kidney cancer
W. Marston Linehan et al.
SEMINARS IN CANCER BIOLOGY (2013)
Metabolic profiling reveals key metabolic features of renal cell carcinoma
Gareth Catchpole et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Biomarkers Predicting Outcome in Patients with Advanced Renal Cell Carcinoma: Results from Sorafenib Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Carol Pena et al.
CLINICAL CANCER RESEARCH (2010)
Urinary Biomarkers for the Early Diagnosis of Kidney Cancer
Jeremiah J. Morrissey et al.
MAYO CLINIC PROCEEDINGS (2010)
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Aquaporins - new players in cancer biology
A. S. Verkman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature
SN Chawla et al.
JOURNAL OF UROLOGY (2006)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
AS Levey et al.
KIDNEY INTERNATIONAL (2005)
Natural history of small renal cell carcinoma: Evaluation of growth rate, histological grade, cell proliferation and apoptosis
M Kato et al.
JOURNAL OF UROLOGY (2004)
Solid renal tumors: An analysis of pathological features related to tumor size
I Frank et al.
JOURNAL OF UROLOGY (2003)
Share Paper
